Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Potential Applications Potential applications BPC-157 is a small peptide that demonstrates a variety of actions in preclinical work applicable to fertility
Inclusion Criteria Exclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive once-weekly subcutaneous injections of CagriSema or placebo for up to 40 weeks, with dose escalation periods for active comparators Follow-up Participants are monitored for safety and effectiveness after treatment What Are the Treatments Tested in This Trial
They do not necessarily have the cheapest sticker price
Yes, it is often utilized alongside other supportive treatments
US$ 27.60
US$ 28.81
US$ 23.93
US$ 20.96
US$ 28.40
US$ 14775.00
Sold : Login>>
